Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × aldesleukin × 90 days × Clear all

Sponsor

Conditions

Melanoma 7 Neoplasm Metastasis 5 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid 2 Leukemia 2 Colorectal Neoplasms 2 Carcinoma, Merkel Cell 2 Vulvar Diseases 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Penile Neoplasms 1 Papillomavirus Infections 1

Interventions

ruxolitinib 8 fludarabine 4 Tacrolimus 4 Cyclophosphamide 4 Whole-Body Irradiation 3 Stem Cell Transplantation 3 Specimen Handling 3 venetoclax 2 fludarabine phosphate 2 Mycophenolic Acid 2 Melphalan 2 Decitabine 2 Busulfan 2 Biopsy 2 Azacitidine 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 veliparib 1 selinexor 1 reparixin 1 piperine 1 pevonedistat 1 navitoclax 1 merphos 1 iadademstat 1 fedratinib 1 elotuzumab 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 axatilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡